Cleared Traditional

K071164 - LIFE+CEL BATTERY

K071164 is an FDA 510(k) clearance for LIFE+CEL BATTERY, manufactured by Amco International Manufacturing & Design, Inc.. The device is a Class 2 Cardiovascular device with product code MHX cleared through the Traditional 510(k) pathway after a 225-day FDA review.

K071164 · Amco International Manufacturing & Design, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2007
Decision
225d
Days
Class 2
Risk

K071164 is an FDA 510(k) clearance for the LIFE+CEL BATTERY. Classified as Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) (product code MHX), Class II - Special Controls.

Submitted by Amco International Manufacturing & Design, Inc. (Elizabeth, US). The FDA issued a Cleared decision on December 7, 2007 after a review of 225 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Amco International Manufacturing & Design, Inc. devices

FDA 510(k) Submission Details - K071164

510(k) Number K071164 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 26, 2007
Decision Date December 07, 2007
Days to Decision 225 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
100d slower than avg
Panel avg: 125d · This submission: 225d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MHX Device Classification - Class 2, Special Controls

Product Code MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)

All 358
Devices cleared under the same product code (MHX) and FDA review panel - the closest regulatory comparables to K071164.
SURESIGNS VM SERIES PATIENT MONITOR, MODELS VM4, VM6, VM8, VM3 AND VS3
K080495 · Philips Medical Systems · Mar 2008
NIHON KOHDEN BEDSIDE MONITOR, MODEL BSM-6000S SERIES
K080342 · Nihon Kohden America, Inc. · Feb 2008
MODIFICATION TO DASH 3000, 4000, 5000 MONITOR AND ACCESSORIES
K073462 · Ge Medical Systems Information Technologies · Jan 2008
PM-7000 PATIENT MONITOR
K072346 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Nov 2007
CARESCAPE V100
K073203 · Ge Medical Systems Information Technologies · Nov 2007
PHILIPS MP2 AND X2 INTELLIVUE PATIENT MONITORS
K072070 · Philips Medizinsysteme Boeblingen GmbH, Cardiac AN · Aug 2007